Leveraging AI-Powered Health Tools for Behavioral Health
Distinguished AI Speaker Series
Leveraging AI-Powered Health Tools for Behavioral Health
Millions of people who need mental health or substance use care don’t get it. Digital tools are helping to close that gap. Smartphones and wearables can capture a continuous stream of behavioral, physiological, and contextual data, and AI can turn those signals into personalized support anytime and anywhere. In this presentation, Dr. Marsch will discuss the science, impact and rapidly evolving world of precision digital assessments and therapeutics, with a particular focus on the opportunities and challenges of AI-powered tools for mental health and substance use. Dr. Marsch will describe what these precision digital health tools can already do and where the evidence is still catching up. Attendees will leave with an understanding of how these tools can expand access to care, improve outcomes, and lower costs.
Dr. Lisa A. Marsch is the Founding Director of the Dartmouth Center for Technology and Behavioral Health (CTBH), a designated “Center of Excellence” supported by the U.S. National Institutes of Health. She is also the Director of the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network and the Andrew G. Wallace Professor within the Departments of Psychiatry and Biomedical Data Science at the Geisel School of Medicine at Dartmouth College. CTBH is an interdisciplinary Center housed at Dartmouth and includes partners across the U.S. and internationally. This Center uses science to inform the development, evaluation, and sustainable implementation of digital therapeutics and other digital health tools for behavior change targeting a wide array of populations and health behaviors. These tools are designed to deliver engaging and effective health monitoring and health behavior interventions anytime and anywhere and to collectively lead to transformations in the delivery of science-based health care.
Dr. Marsch is a regular keynote speaker at national and international meetings (including invited presentations at the White House, U.S. Congress, the World Bank, the United Nations and for the US Surgeon General). She has served as a consultant to the Department of Mental Health and Substance Abuse at the World Health Organization and on the National Advisory Council to the National Institute on Drug Abuse at the National Institutes of Health. She serves on the Scientific Advisory Board of the Campus for Research Excellence and Technological Enterprise (CREATE) in Singapore.